Bioindustry in South Korea: an analitical overview and main perspectives of its development

This article provides an analytical overview of South Korea's bioindustry, examining its current status, achievements, and challenges. The article covers various aspects of the economy, including innovation opportunities, government policies, economic impact, and social change. The analysis identifies key achievements, including South Korea's leadership in biopharmaceutical production and innovation, and addresses challenges such as global competition and climate change. It outlines key future development prospects, highlighting the potential of digital healthcare, personalized medicine, and green biotechnology to position South Korea as a leader in the bioeconomy. It also highlights lessons that can be learned from South Korea's experience and their applicability to other countries, including Ukraine and Poland, that are seeking to strengthen their bioeconomy and bioindustry potential. Considering the strategic approach of South Korea, this study aims to identify valuable ideas for promoting innovation, ensuring sustainable development and positioning the bioindustry as a driving force for national economic growth. The analytical analysis of this work concerns the coverage of the current state of industrial production and areas of scientific research in classical biotechnology to improve existing and develop new bioengineering technologies, which are aimed at developing the strategic importance of the bioindustry for achieving sustainable development of the country. Aim. The article purposed to analyze the current state, key achievements, challenges, and prospects of the South Korean bioindustry, focusing on obtaining valuable knowledge and practices that can be adapted to promote the development of the bioindustry in Ukraine and Poland. Materials and Methods. Methodological analysis and abstract-logical method of generalizing the criteria for assessing the formation, development, and integration of biotechnological production into the structure of the global output of safe products, as well as bioproducts for improving health and rejuvenation. Results. The article describes the current state of key industries based on the Korean bioindustry classification code KS J 1009: biopharmaceutical, biochemical, and bioenergy, biofood, bioenvironmental, biomedical equipment, and bioinstrument & bioequipment, bioresource, and bioservice industries. Each sector is characterized by distinct dynamics of growth, levels of innovation implementation, and integration into national and global bioeconomic strategies. Conclusion. The analysis highlights both the technological achievements and structural priorities shaping South Korea's modern bioindustry.